by Eric Christianson | Sep 5, 2021 | Clinical Guideline Updates For Pharmacists
In this article, we provide the latest acne treatment guidelines as well as clinical pearls of the most commonly used agents. Acne is a very common disease that plagues teens and young adults. Acne can persist into later adulthood, but the incidence is far less...
by Eric Christianson | Sep 1, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
At the end of July, the FDA approved Semglee (insulin glargine-yfgn) as the first-ever interchangeable drug in the United States. It is essentially a copy of Lantus, a long-acting basal insulin. Patients will have questions about the interchangeable status of...
by Eric Christianson | Aug 29, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Prolactin is a hormone that is elevated during pregnancy and peaks in serum levels at delivery. It stimulates lactation and maternal behavior under normal circumstances. Prolactin release from the pituitary gland is inhibited by dopamine, so drugs that inhibit...
by Eric Christianson | Aug 25, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Gabapentin and pregabalin are anticonvulsants utilized in a wide array of conditions. These drugs share a similar chemical structure and share many of the same uses, so let’s take a look at gabapentin versus pregabalin? Mechanism of action: The precise mechanism...
by Eric Christianson | Aug 22, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Anticholinergic medications are well known for their often dose-limiting adverse effects, so do any of the medications typically used in the treatment of lower urinary tract symptoms (LUTS) associated with BPH stand above the others with a more favorable adverse...
